Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MAVERICC: Bevacizumab + Chemo in mCRC
NCT01374425Phase 2Completed
- Sponsor
- Genentech
- Start
- Aug 2011
- Primary completion
- May 2015
- Modality
- Monoclonal Antibodies
- Countries
- 7
01
Overview
A Phase 2 trial of bevacizumab in metastatic colorectal cancer (mCRC), sponsored by Genentech. Started Aug 2011; status: completed.
02
Drugs
bevacizumab
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT01374425.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01374425.